What is CRITERIUM?
CRITERIUM operates as a full-service Clinical Research Organization (CRO), dedicated to optimizing clinical trial processes for pharmaceutical firms and research institutions. With a legacy spanning over three decades, the company excels in reducing costs and accelerating the time-to-market for new therapies. Their comprehensive service portfolio includes end-to-end clinical trial management, retrospective study analysis, and the deployment of advanced technological solutions. CRITERIUM's therapeutic expertise encompasses critical areas such as oncology, dermatology, and orthopedics, with a particular emphasis on managing complex cancer trials. Strategic collaborations with prominent universities in the USA and Canada bolster their capabilities in translational research, positioning them as a key player in advancing medical innovation.
How much funding has CRITERIUM raised?
CRITERIUM has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for CRITERIUM?
The recent major strategic investment signals CRITERIUM's readiness for its next phase of growth, likely focused on scaling operations, expanding service offerings, and potentially entering new therapeutic markets. This capital infusion is expected to fuel innovation in their technology solutions and further strengthen their collaborative networks. As a late-stage company, CRITERIUM is poised to leverage this financing to solidify its market leadership and enhance its impact on pharmaceutical development and patient outcomes.
See full CRITERIUM company page
